We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

D-chiro-Inositol in Overweight Type 1 Diabetes Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02730949
Recruitment Status : Completed
First Posted : April 7, 2016
Last Update Posted : April 7, 2016
Information provided by (Responsible Party):
Professor Paolo Pozzilli, Campus Bio-Medico University

Brief Summary:

The purpose of this pilot study was to evaluate the effect of D-chiro-Inositol (DCI) oral supplementation in addiction to folic acid compared to folic acid alone on glycaemic control as assessed by HbA1c in overweight or obese T1D patients undergoing intensive insulin therapy.

A 24 weeks, prospective, randomized control trial was carried out in T1D patients, aged 17-50 years (13 males, 13 females), with disease duration > 1 year and BMI >25, attending as outpatients the Endocrinology and Diabetes Unit of University Campus Bio-Medico in Rome

Condition or disease Intervention/treatment Phase
Type 1 Diabetes Dietary Supplement: D-chiro-inositol Dietary Supplement: Folic Acid Phase 3

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 26 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Pilot Study of D-Chiro-Inositol Plus Folic Acid in Overweight Patients With Type 1 Diabetes
Study Start Date : March 2014
Actual Primary Completion Date : May 2015
Actual Study Completion Date : December 2015

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: 1 g D-chiro-Inositol + 400 mcg Folic Acid
1 g D-chiro-Inositol + 400 mcg folic acid once daily
Dietary Supplement: D-chiro-inositol
Treated group

Dietary Supplement: Folic Acid
Control group

Active Comparator: 400 mcg folic
400 mcg folic acid only once daily
Dietary Supplement: Folic Acid
Control group

Primary Outcome Measures :
  1. efficacy of DCI oral supplementation on metabolic control [ Time Frame: 6 months ]
    efficacy of DCI oral supplementation on metabolic control as assessed by HbA1c (%)

Secondary Outcome Measures :
  1. BMI kg/m2 [ Time Frame: 6 months ]
    reduction of BMI

  2. Insulin Requirement (I.R.) IU/kg [ Time Frame: 6 months ]
    reduction of I.R.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   17 Years to 50 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • T1D patients
  • aged 17-50 years
  • disease duration > 1 year
  • BMI >25

Exclusion Criteria:

  • learning disabilities
  • presence of chronic conditions potentially able to influence daily activities (visual or auditory disability, motor impairment for neurological or orthopaedic problems).
  • T1D patients affected from diabetic complications
  • pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02730949

Layout table for location information
University Campus Bio Medico
Rome, Italy, 00128
Sponsors and Collaborators
Campus Bio-Medico University
Layout table for investigator information
Principal Investigator: Paolo Pozzilli, MD University Campus Bio-medico
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Professor Paolo Pozzilli, Prof, Campus Bio-Medico University
ClinicalTrials.gov Identifier: NCT02730949    
Other Study ID Numbers: 16/14PARComETCBM
First Posted: April 7, 2016    Key Record Dates
Last Update Posted: April 7, 2016
Last Verified: April 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Professor Paolo Pozzilli, Campus Bio-Medico University:
D-Chiro-Inositol, type 1 diabetes
Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetes Mellitus
Diabetes Mellitus, Type 1
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Autoimmune Diseases
Immune System Diseases
Body Weight
Folic Acid
Vitamin B Complex
Physiological Effects of Drugs